45 results
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
23 Apr 20
Avenue Therapeutics Announces Presentation of IV Tramadol E-Posters
9:00am
first dose), total consumption of rescue medicine and Patient Global Assessment. IV tramadol 50 mg was statistically significantly superior to placebo … Global Assessment.
IV tramadol 50 mg was well tolerated in this real-world trial, with only 4% of patients discontinuing for adverse events. The most
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
25 May 18
Regulation FD Disclosure
8:30am
Patient Global Assessment, captures patients’ perception of treatment Rapid onset of efficacy Statistically significant pain reduction seen as early … Reported Outcome The Patient Global Assessment (PGA), which captures patients’ perception of the treatment, demonstrated statistically significant
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
21 May 18
Avenue Therapeutics Announces Positive Topline Phase 3 Data for Intravenous Tramadol in the Management of Postoperative Pain
8:15am
by SPID48. The key secondary endpoints included SPID24, total consumption of rescue medicine and Patient Global Assessment, which captures patients … tramadol 50 mg achieved statistically significant improvement in pain reduction as early as ½ hour (the first assessment timepoint) after dosing
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
3 Jun 19
Avenue Therapeutics Announces Positive Topline Data from Second Pivotal Phase 3 Study of Intravenous Tramadol in the Management of Postoperative Pain
8:45am
tramadol compared to placebo as measured by SPID24. The key secondary efficacy endpoints included Patient Global Assessment at 24 hours (PGA 24), SPID48
8-K
EX-10.4
na41kgncvu
14 Nov 18
Entry into a Material Definitive Agreement
12:53pm
8-K
EX-10.3
an6s ym2pu
14 Nov 18
Entry into a Material Definitive Agreement
12:53pm
10-12G
u3v21l
12 Jan 17
Registration of securities
12:00am
10-12G/A
bb2mg un1
13 Mar 17
Registration of securities (amended)
12:00am
10-12G/A
we1c jru92
6 Mar 17
Registration of securities (amended)
12:00am
8-K
EX-10.1
nvaajyp68x dla
14 Nov 18
Entry into a Material Definitive Agreement
12:53pm
424B4
8qdyqdlb2l2qkir9 xz7
11 Oct 22
Prospectus supplement with pricing info
8:27am